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Abstract
Themalaria parasite Plasmodium knowlesi, previously associated only with infection of ma-
caques, is now known to infect humans as well and has become a significant public health
problem in Southeast Asia. This species should therefore be targeted in vaccine and therapeu-
tic strategies against humanmalaria. Apical Membrane Antigen 1 (AMA1), which plays a role
in Plasmodiummerozoite invasion of the erythrocyte, is currently being pursued in human vac-
cine trials against P. falciparum. Recent vaccine trials in macaques using the P. knowlesi
orthologue PkAMA1 have shown that it protects against infection by this parasite species and
thus should be developed for human vaccination as well. Here, we present the crystal struc-
ture of Domains 1 and 2 of the PkAMA1 ectodomain, and of its complex with the invasion-in-
hibitory monoclonal antibody R31C2. The Domain 2 (D2) loop, which is displaced upon
binding the Rhoptry Neck Protein 2 (RON2) receptor, makes significant contacts with the anti-
body. R31C2 inhibits binding of the Rhoptry Neck Protein 2 (RON2) receptor by steric blocking
of the hydrophobic groove and by preventing the displacement of the D2 loop which is essen-
tial for exposing the complete binding site on AMA1. R31C2 recognizes a non-polymorphic
epitope and should thus be cross-strain reactive. PkAMA1 is much less polymorphic than the
P. falciparum and P. vivax orthologues. Unlike these two latter species, there are no polymor-
phic sites close to the RON2-binding site of PkAMA1, suggesting that P. knowlesi has not de-
veloped a mechanism of immune escape from the host’s humoral response to AMA1.
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Introduction
Human malaria was long thought to be restricted to infection by four Plasmodium species: P.
falciparum, P. vivax, P.malariae and P. ovale. It has now been confirmed, however, that natural
human infection also occurs with P. knowlesi [1], a species hitherto associated only with ma-
caque hosts. Human infection by P. knowlesi, previously confused with infection by the less vir-
ulent P.malariae, is quite widespread in Southeast Asia and can lead to mortality [2–4].
Accordingly, there is a need to include P. knowlesi in therapeutic and vaccine strategies against
human malaria.
Apical Membrane Antigen 1 (AMA1), a type 1 transmembrane protein of the Plasmodium
parasite, includes an ectodomain, a transmembrane region and a cytoplasmic domain. The
ectodomain comprises three domains referred to as Domain 1, Domain 2 and Domain 3.
AMA1 is produced in the microneme organelles and transferred to the parasite surface just
prior to or during red blood cell (RBC) invasion [5]. First detected in P. knowlesi [6], AMA1
was later found in other Plasmodium species, as well as in other members of the Apicomplexa
phylum [7–9]. AMA1 appears to be essential for invasion since, for several Plasmodium spe-
cies, antibodies raised against the ectoplasmic region of the protein have been shown to inhibit
invasion, and immunization with AMA1 in animal models protects against infection [10–14].
In spite of significant polymorphism, it is a leading malaria vaccine candidate and vaccine for-
mulations based on the P. falciparum AMA1 ectodomain are currently being pursued in clini-
cal trials [15, 16].
Crystal structures of AMA1 from Plasmodium species and other members of the Apicom-
plexa phylum (P. vivax [17], P. falciparum [18], Toxoplasma gondii [19], Babesia babesia [20]
and Neospora caninum [20]) have revealed the presence of a hydrophobic groove on Domain 1
of the protein. This region is targeted by invasion-inhibitory monoclonal antibodies [21, 22],
suggesting that it forms a receptor-binding site. The receptor for AMA1 is the Rhoptry Neck
Protein (RON) complex, which is transferred from the rhoptries to the host cell membrane
during invasion [23, 24]. In particular, it has been shown in T. gondii and P. falciparum that
AMA1 interacts directly with the component RON2 of the receptor [25,26]. Furthermore, crys-
tal structures of the complex formed between TgAMA1 or PfAMA1 and a peptide derived
from the extracellular region of RON2 from each of these respective species have confirmed
that the hydrophobic groove on AMA1 contributes to the receptor-binding site [27, 28]. More-
over, these studies showed that, in addition to the hydrophobic groove, an adjacent surface that
becomes exposed upon displacement of a flexible region known as the Domain 2 (D2 loop)
also contributes to the RON2-binding site. The AMA1-RON interaction appears to take place
at the tight junction, which forms between the merozoite and RBC membranes as the parasite
enters the host cell and is a critical component in the invasion process [29]. This model has
been subject to controversy, however, with arguments for and against [30–33], showing that
further experimental analysis is required to clarify this issue.
The monoclonal antibody (mAb) R31C2, raised in rats against the W1 variant of P. knowlesi
merozoites, is specific for Plasmodium knowlesi AMA1 (PkAMA1) and inhibits in vitromulti-
plication of the parasite [6]. R31C2 was the first anti-AMA1 mAb to be characterized (along
with mAb R32C3) and has proved to be a useful tool in dissecting the role of AMA1 in RBC in-
fection. Since its Fab fragment is also a highly effective inhibitor, it was concluded that the
mAb acts by blocking a receptor-binding site on PkAMA1 [34]. Electron microscopy studies of
P. knowlesimerozoites in the presence of R31C2 have shown that the parasite makes extensive
contacts with the RBC surface, characteristic of the random attachment that occurs during the
first stage of invasion [35]. However, no apical attachment to the RBC surface nor the subse-
quent formation of a tight junction between the merozoite and RBC membranes—the ensuing
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